Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suxin Tongqiao granules in persistent allergic rhinitis
CTR20230828Phase 2Completed
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Mar 2023
- Countries
- 1
01
Overview
A Phase 2 trial of Zixin Biqiu Granules in allergic rhinitis (AR), sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Mar 2023; status: completed.
02
Drugs
Zixin Biqiu Granules
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on CTR20230828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230828.